Costco stock slips after CPI; 3 near-term dates investors are watching for COST
13 January 2026
1 min read

Costco stock slips after CPI; 3 near-term dates investors are watching for COST

New York, Jan 13, 2026, 11:14 ET — Regular session

  • Costco shares slipped roughly 1.3%, dragged down by fresh U.S. inflation figures and some early earnings reports.
  • The stock bucked the trend set by some big-box peers, even though Costco climbed higher the day before.
  • Upcoming dates: Costco’s shareholder meeting on Jan. 15, January sales figures out Feb. 4, followed by the March earnings call.

Costco Wholesale shares dipped Tuesday, surrendering some of Monday’s gains as investors absorbed new inflation data and shuffled their bets in retail stocks.

The pullback is significant since Costco typically acts as a “quality” consumer staple—investors bid it up when economic worries rise, then trim positions as rates or growth forecasts move. Tuesday’s CPI reading fueled ongoing rate-cut chatter, stirring volatile action in defensive stocks.

This comes just before a packed schedule of Costco-specific dates, as investors hunt for clues on traffic, renewal rates, and margins ahead of the upcoming earnings season. 1

Costco slipped to $931.05 by late morning. Walmart, Target, and BJ’s Wholesale all gained ground, but Amazon dipped and the S&P 500 ETF crept down slightly.

The Labor Department reported a 0.3% increase in consumer prices for December, with the “core” CPI — excluding food and energy — climbing 0.2%. Over the past year, headline CPI rose 2.7%, while core inflation held at 2.6%. 2

“We got a modicum of good news with today’s CPI report,” said Art Hogan, chief market strategist at B. Riley Wealth, highlighting the cooler core reading. 3

Rate expectations remain on the sidelines for retailers as earnings season heats up, with investors keen to see if companies highlight stronger demand or flag rising costs. Traders have factored in at least two quarter-point rate cuts before year-end, Reuters reported, following the latest data. 4

Costco’s upcoming event is its annual shareholder meeting on Jan. 15, conducted via webcast. Investors will cast votes on directors, auditors, and an advisory resolution on executive compensation, along with other agenda items. 5

Costco will release its January sales figures on Feb. 4. 6

Costco will hold its fiscal second-quarter earnings call on March 5 at 2 p.m. Pacific time. 7

Costco investors face a risk if renewal rates weaken, discounts increase, or freight and wage expenses prove more persistent. The stock reacts sharply since it’s priced on “steady growth” expectations. Competition stays fierce as big-box stores and online players battle for the same middle- and upper-income shoppers.

Investors are zeroing in on Jan. 15, bracing for any surprises at the meeting, while Feb. 4 will deliver the first solid data on how demand is shaping up for 2026.

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Pfizer stock slips as CEO says obesity cash-pay market is “almost like Viagra”
Previous Story

Pfizer stock slips as CEO says obesity cash-pay market is “almost like Viagra”

Netflix stock stuck near $90 as Paramount sues over Warner deal and analysts reset targets
Next Story

Netflix stock stuck near $90 as Paramount sues over Warner deal and analysts reset targets

Go toTop